Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Completed 4 Unknown 2 Not yet recruiting 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 58 Neoplasms 52 Colorectal Neoplasms 32 Prostatic Neoplasms 29 Lung Neoplasms 21 Stomach Neoplasms 17 Carcinoma, Non-Small-Cell Lung 16 Carcinoma, Hepatocellular 16 Uterine Cervical Neoplasms 13 Anxiety Disorders 13 Colonic Neoplasms 11 Brain Neoplasms 11 Pancreatic Neoplasms 10 Lymphoma, Follicular 9 Leukemia, Myeloid, Acute 8 Head and Neck Neoplasms 8 Barrett Esophagus 8 Urinary Bladder Neoplasms 7 Rectal Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 7 Disease 7 Diabetes Mellitus 7 Cholangiocarcinoma 7 Sarcoma 6 Recurrence 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Pain 6 Ovarian Neoplasms 6 Motor Activity 6

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Metronidazole 1 Lacteol 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × OTHER × Dysbiosis × Clear all

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡